Monica Celli
About
Monica Celli is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine.
According to data from OpenAlex, Monica Celli has authored 30 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 20 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Monica Celli's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Monica Celli is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Monica Celli collaborates with scholars based in Italy, United Kingdom and Brazil. Monica Celli's co-authors include Stefano Fanti, Giovanni Paganelli, Ugo De Giorgi, Federica Matteucci, Paola Caroli, Anna Sarnelli, Paolo Castellucci, Riccardo Schiavina, Emanuela Scarpi and Cinzia Pettinato and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Molecules.
In The Last Decade
Monica Celli
29 papers receiving 891 citations
Peers
Monica Celli
Lucia Zanoni Italy
Gian Carlo Montini Italy
Gerben J.C. Zwezerijnen Netherlands
Philipp E. Hartrampf Germany
Somali Gavane United States
A D MacVicar United Kingdom
Serkan Kuyumcu Türkiye
Bogdan Małkowski Poland
Tore Bach‐Gansmo Norway
Yukiko Arisaka Japan
Citations per year, relative to Monica Celli Monica Celli (= 1×)
peers
Lucia Zanoni
Countries citing papers authored by Monica Celli
Since
Specialization
Citations
This map shows the geographic impact of Monica Celli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Celli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Celli more than expected).
Fields of papers citing papers by Monica Celli
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Monica Celli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Celli. The network helps show where Monica Celli may publish in the future.
Co-authorship network of co-authors of Monica Celli
This figure shows the co-authorship network connecting the top 25 collaborators of Monica Celli. A scholar is included among the top collaborators of Monica Celli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Celli. Monica Celli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Feliciani, Giacomo, Monica Celli, E. Menghi, et al.. (2022). Radiomics Analysis on [68Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial. Cancers. 14(8). 1888–1888.
2.
Giorgi, Ugo De, Maddalena Sansovini, Stefano Severi, et al.. (2021). Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial. British Journal of Cancer. 125(9). 1226–1232.
3.
Matteucci, Federica, Priscilla Guglielmo, Natale Quartuccio, et al.. (2021). [18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review. Current Medical Imaging Formerly Current Medical Imaging Reviews. 18(4). 363–371.
4.
Tumedei, Maria Maddalena, Sara Ravaioli, Federica Matteucci, et al.. (2021). Spotlight on PSMA as a new theranostic biomarker for bladder cancer. Scientific Reports. 11(1). 9777–9777.
5.
Caroli, Paola, Ugo De Giorgi, Monica Celli, et al.. (2020). 68Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy. Biomedicines. 8(12). 536–536.
6.
Paganelli, Giovanni, Anna Sarnelli, Stefano Severi, et al.. (2020). Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 47(13). 3008–3017.
7.
Belli, Maria Luisa, Emilio Mezzenga, Valentina Di Iorio, et al.. (2020). A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods. Journal of Visualized Experiments.
8.
Celli, Monica, Ugo De Giorgi, Paola Caroli, et al.. (2020). Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 87–94.
9.
Sarnelli, Anna, Maria Luisa Belli, Valentina Di Iorio, et al.. (2019). Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol. Molecules. 24(3). 621–621.
10.
Carr, Robert, Juliano J. Cerci, Monica Celli, et al.. (2019). Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment 18F-FDG PET in Diffuse Large B-Cell Lymphoma. Journal of Nuclear Medicine. 61(7). 999–1005.
11.
Caroli, Paola, Israel Sandler, Federica Matteucci, et al.. (2018). 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients. European Journal of Nuclear Medicine and Molecular Imaging. 45(12). 2035–2044.
12.
Bravaccini, Sara, Maurizio Puccetti, Martine Bocchini, et al.. (2018). PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis. Scientific Reports. 8(1). 4254–4254.
13.
Bongiovanni, Alberto, Federica Recine, Monica Celli, et al.. (2017). Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT. Medicine. 96(46). e8567–e8567.
14.
Beheshti, Mohsen, Felix M. Mottaghy, Florian F. Behrendt, et al.. (2015). 18F-NaF PET/CT: EANM procedure guidelines for bone imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42(11). 1767–1777.
15.
Haroon, Athar, Lucia Zanoni, Monica Celli, et al.. (2015). Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients. Nuclear Medicine Communications. 36(11). 1065–1075.
16.
Carr, Robert, Stefano Fanti, Diana Páez, et al.. (2014). Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma. Journal of Nuclear Medicine. 55(12). 1936–1944.
17.
Castellucci, Paolo, Francesco Ceci, Tiziano Graziani, et al.. (2014). Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging11C-Choline PET/CT Scan Before Salvage Radiation Therapy?. Journal of Nuclear Medicine. 55(9). 1424–1429.
18.
Nanni, Cristina, Elena Zamagni, Monica Celli, et al.. (2012). The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM). Clinical Nuclear Medicine. 38(2). e74–e79.
19.
Fuccio, Chiara, Riccardo Schiavina, Paolo Castellucci, et al.. (2011). Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study. European Journal of Nuclear Medicine and Molecular Imaging. 38(11). 1985–1989.
20.
Cerci, Juliano J., Evelinda Trindade, Valéria Buccheri, et al.. (2011). Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin Lymphoma Across Jurisdictions. Clinical Lymphoma Myeloma & Leukemia. 11(4). 314–320.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lucia Zanoni Breakdown of academic impact, for papers by Gian Carlo Montini Breakdown of academic impact, for papers by Gerben J.C. Zwezerijnen Breakdown of academic impact, for papers by Philipp E. Hartrampf Breakdown of academic impact, for papers by Somali Gavane Breakdown of academic impact, for papers by A D MacVicar Breakdown of academic impact, for papers by Serkan Kuyumcu Breakdown of academic impact, for papers by Bogdan Małkowski Breakdown of academic impact, for papers by Tore Bach‐Gansmo Breakdown of academic impact, for papers by Yukiko Arisaka